Objective: Ultrasound-guided (USG) cannulation of the brachiocephalic vein (BCV) has been shown to be technically easy. We hypothesised that adoption of USG in-plane cannulation of the BCV as the primary approach to central venous cannulation at our institution would lead to central venous cannulation for a greater variety of indications.
Introduction
T he brachiocephalic vein (BCV) occurs at the confluence of the internal jugular (IJ) and subclavian veins. The paired BCVs merge into the superior vena cava. The left BCV may rarely continue as a persistent left superior vena cava. BCV was previously known as the innominate vein or the 'vein without a name'. On the right side, BCV t is sometimes referred to as the superior portion of the superior vena cava, whereas on the left side, it is sometimes referred to as the continuation of the subclavian vein.
Cannulation of BCV was initially described in 1965 by Yoffa (1) as a landmark-based approach in the supraclavicular fossa. Illustrations in that study clearly indicated that the needle was intended to enter what we now call BCV, although Yoffa used the older nomenclature of 'subclavian' and 'Pirogoff's confluence'. This approach may not have gained popularity because of early reports of pneumothorax in 1969 (2) . Whether owing to concerns of causing pneumothorax, or confusion in the nomenclature, widespread adoption did not occur, leading to some authors to call the BCV approach 'the forgotten central line' (3, 4) .
With the introduction of ultrasound into routine clinical practice, the brachiocephalic approach has regained interest because of the superficial location of BCV, and lack of bone overlying the vein, makes it possible to visualise the entire path of An editorial comment on this article is available at page 127. the needle during cannulation. In 2011, Breschan et al. (5) first described USG cannulation of BCV in children. They studied placement in children aged 26 months to 8 years.
In the same year, Rhondali et al. (6) described placement in patients weighing <10 kg. Other studies have assessed placement in patients weighting <5 kg (7, 8) . Three studies noted that USG BCV cannulation is technically easy in children in the paediatric intensive care unit and neonatal intensive care unit (8) (9) (10) .
Methods
The internal review boards of Covenant Children's Hospital and Texas Tech University Health Sciences Center waived the requirement for informed consent for this retrospective, observational study. The study was conducted as per the protocol approved by both internal review boards.
A single anaesthesiologist began performing USG cannulation of BCV in January 2012 at our institution shortly after its initial description in the literature. Before that, central lines were infrequently placed; therefore, a case-control study was not possible given the lack of a historical control group. Patients in this study were consecutive cases of central venous cannulation by the author during calendar years 2012-2014. This study analyses the duration of insertion and characterisation of venous access at removal as primary outcome measures. Patients with central line placement were identified by billing records and case logs. Charts were reviewed via the electronic medical record for measurements of interest. Fifty-seven patients were identified. Six adults were excluded from this review, leaving 49 paediatric patients for review. Statistical analysis was performed with basic spreadsheet functions such as average, mean and standard deviation.
The SonoSite S-Series machine (Bothell, WA, USA) was used with a sterile sheath probe cover. For children weighing <10 kg, a narrow linear 13-6 MHz probe (LX25x, SonoSite) was used, and a 5-Fr 8-cm double-lumen catheter was chosen. For very small infants, a 5-cm double-lumen catheter was chosen, especially if cannulation of the right side was anticipated. For children weighing >10 kg, a linear 15-5 MHz probe (HFL50x, SonoSite) was used along with a 5-Fr 8-or 12-cm catheter. Portable radiograph confirmed placement before the child left the operating room.
The entry site of the catheter was covered with a chlorhexidine gluconate impregnated patch (BIOPATCH ® Ethicon, Somerville, NJ, USA) and secured with Mastisol ® (Ferndale IP Inc., Ferndale, MI, USA) and Tega-derm™ (3M, St. Paul, MN, USA).
Coincident with our adoption of the USG BCV cannulation technique, our institution also implemented an algorithm intended to limit the number of attempts made to place a PIV cannula in children to prevent trauma and loss of useful veins. The "Difficult IntraVenous Algorithm" advised that after 5 attempts, or twenty minutes of attempts at placing a PIV, the involved team caring for the child was to pause and reflect on the value of continuing to search for a PIV, or consider another method of establishing venous access. In the operating room, the most common method chosen in this situation was USG BCV cannulation by anaesthesiology.
Results
Forty-nine patients were identified, 20 weighing <10 kg and 29 weighing >10 kg. Cannulation was successful in all patients. Patient weights ranged from 1.4 to 88 kg. Descriptive and calculated variables are presented in Table 1 . All central lines were placed in the operating room during the induction of anaesthesia. Nine catheters were placed for resuscitation during emergency surgery, three of which were in infants weighing <10 kg. Fifteen catheters were placed for known or encountered difficult intravenous access or no intravenous access status. The rest of the catheters were placed for craniotomy, thoracic, major abdominal or major orthopaedic surgeries.
Central line cannulation of the BCV was successful in all patients. Difficulty was noted in three patients, one with arterial puncture, and two with difficulty threading the wire. All three were managed successfully by changing the approach to the contralateral side. Placement was on the left side in 31 (63.2%) patients.
The average insertion duration was 6.3±3.77 (2-20) days. In patients weighing <10 kg, the average insertion duration was 7±4.10 (3-20) days, which remained in place slightly longer than that in patients weighing >10 kg. There were no cases of thrombosis, infection, accidental removal or pneumothorax. Three patients who experienced fever postoperatively with temperature >38.1ºC had their central lines removed per sepsis workup protocol. All three had sources of infection (surgical) far removed from site of cannulation. Short courses of total parenteral nutrition (TPN) were administered in 11 (22.4%) patients. PIV cannula was removed within an average of 3 days post-operatively as per the hospital protocol or failure of PIV, and the central lines were kept in place as the primary venous access in 40% of patients. The central lines were removed within 2 hours of the patients being discharged from the hospital 79.6% of the time. In patients weighing <10 kg, the central lines were more likely to be retained until discharge with 95% (19/20) remaining until being discharged home.
Discussion
The benefits of USG cannulation of BCV include visualisation of the needle along its entire path from the skin to Turk J Anaesthesiol Reanim 2017; 45: 153-7 the vein, patient comfort when the catheter is secured over the top of the shoulder and ease of maintaining dressings, which may reduce incidence of early removal for contamination concerns. Cannulation of IJ, which despite being a large vein that is easy to cannulate, is often very uncomfortable for patients. Neck movement often disrupts the integrity of the catheter dressing, rendering the insertion site vulnerable to contamination. Likewise, it is difficult to maintain barrier sterility with femoral central lines because of patient movement, and patients may remain immobile owing to discomfort with femoral lines. The supraclavicular approach to BCV is unique in that the catheter dressing usually tightly adheres and inconspicuously drapes over the shoulder in a manner that does not restrict arm or neck motion. It does not transverse the pectoralis muscle; therefore, it is less likely to limit upper extremity movement compared with the infraclavicular subclavian approach. Cannulation of the BCV has been promoted to have a lower potential for contamination compared to internal jugular, subclavian, or femoral central lines (11) .
Despite variation in nomenclature, the important distinction from other central venous approaches is that the catheter lies predominately within BCV, even if it enters through the distal portion of the subclavian vein into Pirogoff's confluence. Figure 1 shows an artist's rendition of the arrangement of anatomy and the cannulation approach. Figures 2 and 3 demonstrate the USG approach with confirmation of catheter placement obtained with plain film x-ray. The catheter can be secured across the top of the shoulder, and in this position it is not uncomfortable with movement of the head or arm (Figure 4) .
Descriptions of USG cannulation of BCV may be confused with USG infraclavicular and supraclavicular cannulation techniques of the subclavian vein around the mid-portion of the clavicle (12-15) . A recent meta-analysis of 10 studies in adult patients noted that employing ultrasound guidance for subclavian can- (16) . There are insufficient studies of cannulation of BCV in children to complete a similar meta-analysis. , It is reasonable to assume that a reduction in complications would also be found.
In these patients, placement in the left BCV was more common but both sides are reported as being used successfully (17, 18) . It may be helpful to scan both supraclavicular fossa pre-procedure to evaluate which side has the most complete visualisation of the arc of the subclavian/brachiocephalic confluence (7).
Although we did not experience any adverse outcomes, this study was not designed to examine safety compared to other methods.
Conclusion
This study presents descriptive evidence that central lines in BCV are well tolerated by children and are a useful option for intermediate-term venous access in patients undergoing complicated surgery or those with known or anticipated difficult PIV cannulation. This case series uniquely follows patients until discharge and assesses how the central lines were used and managed. These lines were retained post-operatively for an average of 7 days because they are well tolerated by children, easy to care for and useful for intravenous access. USG supraclavicular in-plane cannulation of BCV is both useful and durable.
Ethics Committee Approval: Ethics committee approval was received for this study from the ethics committee of Covenant Children's Hospital and Texas Tech University Health Sciences Center.
Peer-review: Externally peer-reviewed.
Conflict of Interest:
No conflict of interest was declared by the author.
Financial Disclosure: The author declared that this study has received no financial support. 
